Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6246630rdf:typepubmed:Citationlld:pubmed
pubmed-article:6246630lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:6246630lifeskim:mentionsumls-concept:C0341628lld:lifeskim
pubmed-article:6246630lifeskim:mentionsumls-concept:C0037253lld:lifeskim
pubmed-article:6246630lifeskim:mentionsumls-concept:C0725066lld:lifeskim
pubmed-article:6246630lifeskim:mentionsumls-concept:C0332185lld:lifeskim
pubmed-article:6246630pubmed:issue7-8lld:pubmed
pubmed-article:6246630pubmed:dateCreated1980-7-12lld:pubmed
pubmed-article:6246630pubmed:abstractTextSkeletal isotopic exploration is fundamental in patients with prostatic cancer. Bone scintiscan is reliable. Its sensibility can be increased by using new radioactive isotopes and quantitative isotopic explorations. Bone marrow histologic study is indicated in case of a doubtful diagnosis, when there is a discordance between radiological and isotopic exploration.lld:pubmed
pubmed-article:6246630pubmed:languagefrelld:pubmed
pubmed-article:6246630pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6246630pubmed:citationSubsetIMlld:pubmed
pubmed-article:6246630pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6246630pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6246630pubmed:statusMEDLINElld:pubmed
pubmed-article:6246630pubmed:authorpubmed-author:BollackCClld:pubmed
pubmed-article:6246630pubmed:authorpubmed-author:MethlinGGlld:pubmed
pubmed-article:6246630pubmed:authorpubmed-author:OliveuxAAlld:pubmed
pubmed-article:6246630pubmed:authorpubmed-author:MoysesBBlld:pubmed
pubmed-article:6246630pubmed:authorpubmed-author:GrobJ CJClld:pubmed
pubmed-article:6246630pubmed:volume56lld:pubmed
pubmed-article:6246630pubmed:ownerNLMlld:pubmed
pubmed-article:6246630pubmed:authorsCompleteYlld:pubmed
pubmed-article:6246630pubmed:pagination346-50lld:pubmed
pubmed-article:6246630pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6246630pubmed:meshHeadingpubmed-meshheading:6246630-...lld:pubmed
pubmed-article:6246630pubmed:meshHeadingpubmed-meshheading:6246630-...lld:pubmed
pubmed-article:6246630pubmed:meshHeadingpubmed-meshheading:6246630-...lld:pubmed
pubmed-article:6246630pubmed:meshHeadingpubmed-meshheading:6246630-...lld:pubmed
pubmed-article:6246630pubmed:meshHeadingpubmed-meshheading:6246630-...lld:pubmed
pubmed-article:6246630pubmed:meshHeadingpubmed-meshheading:6246630-...lld:pubmed
pubmed-article:6246630pubmed:meshHeadingpubmed-meshheading:6246630-...lld:pubmed
pubmed-article:6246630pubmed:meshHeadingpubmed-meshheading:6246630-...lld:pubmed
pubmed-article:6246630pubmed:meshHeadingpubmed-meshheading:6246630-...lld:pubmed
pubmed-article:6246630pubmed:articleTitle[Recent advances in isotopic exploration of the skeletal system in prostate cancer (author's transl)].lld:pubmed
pubmed-article:6246630pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6246630pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6246630pubmed:publicationTypeEnglish Abstractlld:pubmed